Thrombophilia profile: mutations - factor II (prothrombin G20210A), factor V Leiden (G1691A), MTHFR (C677T, A1298C), factor XIII (V34L), detection of the PAI-1 4G/5G polymorphism, antithrombin III, protein C, protein S
A comprehensive assessment of an inherited tendency to thrombosis: genetic testing for factor II (prothrombin), factor V Leiden, MTHFR, factor XIII and PAI-1 variants, together with measurement of the natural clotting inhibitors antithrombin III, protein C and protein S. It is done after a thrombosis, for pregnancy complications and before hormone therapy, as advised by a doctor.

Preparation and sampling
- Preparation
- Guide to preparing for tests
- Sample
- Blood
- Results available in
- 7 working days
- Where it is done
- All laboratories and map
Description
Who the package is for
Thrombophilia is an increased tendency to form blood clots (thrombi), caused by an imbalance between the mechanisms that promote clotting and those that control it. Clots most often form in the deep veins of the legs and can travel to the lungs (pulmonary embolism), and thrombophilia can also be linked to pregnancy complications by impairing the circulation in the placenta. Inherited forms are caused by gene changes or by an inborn lack of natural clotting inhibitors. The profile is recommended, as advised by a doctor:
- after an episode of venous or arterial thrombosis, particularly at a younger age or without a clear cause;
- after a pulmonary embolism;
- when there are cases of thrombosis at a younger age in the family;
- for recurrent miscarriage or other pregnancy complications;
- before starting hormonal contraception or oestrogen therapy, in people with a personal or family tendency to thrombosis;
- in a pregnancy with an increased risk of thrombosis;
- before prolonged immobility or major surgery, in people at increased risk;
- when an inherited clotting tendency is suspected.
What the package includes
The profile has two complementary parts: genetic testing by RT-PCR and measurement of the natural clotting inhibitors.
- Prothrombin (factor II) G20210A mutation – a mutation that increases the production of prothrombin and therefore the tendency to clot.
- Factor V Leiden (G1691A) mutation – a mutation that makes factor V resistant to breakdown by activated protein C; the most common inherited risk factor for venous thrombosis.
- MTHFR variants (C677T, A1298C) – variants of the gene for an enzyme involved in folate and homocysteine metabolism; they can contribute to raised homocysteine, especially with a lack of folate or vitamin B12.
- Factor XIII variant – the V34L variant of the gene for factor XIII, which stabilises the fibrin clot.
- PAI-1 gene variant (4G/5G) – a variant of the gene for plasminogen activator inhibitor 1, which can affect the breakdown of clots (fibrinolysis).
- Antithrombin III – a natural inhibitor of thrombin and other clotting factors; an inherited deficiency considerably increases the risk of venous thrombosis.
- Protein C – a vitamin K-dependent natural anticoagulant; a deficiency, inherited or acquired, can be linked to thrombosis.
- Protein S – the cofactor of protein C (free protein S is measured); a deficiency reduces the natural control of clotting and favours clot formation.
Why these tests together
The profile combines two complementary types of testing:
- The genetic part detects inherited gene variants linked to increased clotting (factor V Leiden, prothrombin G20210A) or affecting homocysteine metabolism, clot stability and fibrinolysis (MTHFR, factor XIII, PAI-1). These variants do not change during life, so they are tested once.
- The functional part measures the natural clotting inhibitors. An inborn deficiency of these is also an inherited thrombophilia, but it is caused by many different gene changes, so it is detected by measuring the proteins themselves rather than by a targeted genetic test.
This combined approach gives a fuller picture of the tendency to thrombosis and helps to distinguish inherited genetic risk from functional disorders that may also be acquired. The results help the doctor decide on preventive measures (for example protection against thrombosis in pregnancy, after childbirth or before surgery), on the choice of contraception and hormone therapy, on explaining thromboses of unclear cause and on whether family members should be tested.
Preparation
- Blood is taken in the morning, between 7 and 10 am, after a night’s rest and 12 hours without food; you may drink water as usual.
- Antithrombin III, protein C and protein S are affected by anticoagulant medicines: warfarin and acenocoumarol lower protein C and protein S, heparin can lower antithrombin III, and the newer oral anticoagulants can interfere with functional tests. A recent thrombosis, pregnancy and hormonal contraception (which lower protein S), liver disease and acute inflammation also have an effect. The timing of the test should therefore be agreed with your doctor, and you should not stop treatment on your own.
- The genetic tests do not depend on treatment, diet or the time of day and are done once in a lifetime, because inherited genes do not change. If you have had a bone marrow transplant or a recent blood transfusion, say so before sampling.
- If you have them, bring your doctor's referral and medical records: information on previous thromboses in you or your family, on pregnancies and on any anticoagulant treatment you take.
- Avoid strenuous physical exercise for 2 days before the test.
Sample
Venous blood, taken in a single draw into two types of tube: EDTA blood for the genetic tests (from which DNA is extracted) and citrate blood for the clotting tests (from which plasma is obtained).
Interpreting the results
- The genetic result is reported as a genotype for each variant: no change (so-called wild type), heterozygous (a change in one copy of the gene) or homozygous (a change in both copies).
- Factor V Leiden and prothrombin G20210A are established risk factors for venous thrombosis: in heterozygous carriers the risk is moderately increased, and in homozygous carriers or with both mutations together it is considerably higher.
- MTHFR, PAI-1 and factor XIII are susceptibility markers with a variable and limited effect when no other risk factors are present; they are interpreted with caution, and with an MTHFR result it is useful to measure homocysteine as well.
- Low antithrombin III, protein C or protein S can point to an inherited deficiency, but also to acquired causes (anticoagulant treatment, liver disease, recent thrombosis, pregnancy, hormonal contraception), so the result is often repeated to confirm it.
- The overall risk of thrombosis depends on the combination of inherited and acquired factors, such as immobility, surgery, pregnancy and the period after childbirth, oestrogen-containing contraception, obesity and cancer. The profile does not cover antiphospholipid syndrome, which is tested separately.
- When factor V or prothrombin mutations are found, the doctor may recommend genetic counselling and testing of close relatives.
Your doctor interprets the result together with your symptoms and other findings.
Tests in the package
-
Mutations - factor II (prothrombin G20210A)
3.9503.357,50 RSD -
Mutations - factor V Leiden (G1691A)
3.9503.357,50 RSD -
Mutations - MTHFR (C677T, A1298C)
7.2006.120 RSD -
Mutations - factor XIII
4.1003.485 RSD -
Detection of the PAI-1 4G/5G polymorphism
4.1003.485 RSD -
Antithrombin III
3.1002.635 RSD -
Protein C
3.6503.102,50 RSD -
Protein S
3.7503.187,50 RSD
Single-test prices are online prices: 28.730 RSD separately, 28.700 RSD in the package.
Frequently ordered together
How to order tests online?
Choose the tests you need and add them to your cart. Use the site search to find the tests you want more easily.
Payment method:
- Online – payment uses 3D-Secure, a secure authentication protocol that minimises the risk of fraud.
- At the laboratory – order your tests online and pay for them when you come to the laboratory.
After payment, you will receive an email confirming your order, with details of how to prepare for sampling. From then on, you can go to the Sante laboratory you chose when ordering your tests and have your samples taken.